VINC
Vincerx Pharma, Inc.Company Information
- Company Name
- Vincerx Pharma, Inc.
- CIK
- CIK0001796129
- Category
- <br>Emerging growth company
- Ticker: Exchange
- VINC: None
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- VINC
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-08-11
- Last sale
- —
- Shares purchased (TTM)
- 106,958
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-06-30
- Institutional shares owned
- 50
- Shares outstanding
- 3,580,000
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2025-05-15
- Price on filing date
- —
- 1-month reaction
- 14.00%
- 3-month reaction
- -28.00%
Balance Sheet
Values in millions ($)| Line item | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash | - | - | - | - | - | - | - | - | - | - | - | 81 | ||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 5 | 3 | 8 | 5 | 13 | 15 | 7 | 4 | 12 | 46 | - | ||||||
| Restricted Cash Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 5 | 6 | 12 | 18 | 8 | 15 | 23 | 32 | 44 | 56 | 67 | 82 | ||||||
| Marketable Securities Current | - | - | 7 | 8 | - | 0 | 6 | 21 | 35 | 41 | 20 | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | ||||||
| Grants Receivable Current | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | 1 | - | - | ||||||
| Other Assets Current | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 3 | 2 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | - | 0 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | ||||||
| Property Plant And Equipment Net | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | - | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 2 | 2 | ||||||
| Grants Receivable Noncurrent | 0 | - | 2 | 1 | 1 | - | - | - | - | - | - | - | ||||||
| Assets | 5 | 8 | 15 | 22 | 11 | 18 | 26 | 35 | 47 | 59 | 72 | 88 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 6 | 4 | 4 | 5 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 3 | 5 | 5 | 5 | 11 | 6 | 9 | 9 | 11 | 9 | 10 | 10 | ||||||
| Accrued Liabilities Current | 0 | 3 | 2 | 2 | 2 | 2 | 5 | 4 | 3 | 4 | 4 | 4 | ||||||
| Operating Lease Liability Current | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Derivative Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | ||||||
| Other Liabilities Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Liabilities | 3 | 5 | 6 | 6 | 12 | 7 | 11 | 11 | 13 | 12 | 13 | 13 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 196 | 192 | 190 | 189 | 171 | 170 | 172 | 171 | 170 | 167 | 167 | 165 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -194 | -189 | -181 | -173 | -172 | -159 | -157 | -147 | -136 | -119 | -108 | -91 | ||||||
| Stockholders Equity | 2 | 3 | 9 | 15 | -1 | 11 | 16 | 24 | 34 | 48 | 60 | 74 | ||||||
| Liabilities And Stockholders Equity | 5 | 8 | 15 | 22 | 11 | 18 | 26 | 35 | 47 | 59 | 72 | 88 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | ||||||
| Common Stock Shares Issued | 5 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Shares Outstanding | 5 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Stockholders Equity Note Stock Split Conversion Ratio1 | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVincerx Pharma, Inc. (VINC) — SEC Financial Statements & Analysis
Vincerx Pharma, Inc. (VINC) is a pharmaceutical preparations company. Vincerx Pharma, Inc. trades on None as: VINC. Vincerx Pharma, Inc. (VINC)'s most recent SEC filing is a Form 10-Q for the period ended 2025-03-31, filed with the SEC on 2025-05-15. Based on that filing, Vincerx Pharma, Inc. carries a market cap of $1.89M, a P/E ratio of -0.08x, a P/B ratio of 0.92x, an enterprise value of $-2.63M, and an EV/EBITDA multiple of 0.10x. On profitability, it posts a Return on Equity (ROE) of -3136.43%, a Return on Assets (ROA) of -287.21%, and a Return on Invested Capital (ROIC) of -844.17%. Per share, it reports EPS of $-6.33, diluted EPS of $-6.33, free cash flow per share of $-6.38, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -40.31% year-over-year and EPS growth of -81.91% year-over-year. On the balance sheet, it maintains a current ratio of 1.79x, a quick ratio of 1.74x, working capital of $2.07M, a debt-to-equity ratio of 1.27x, a debt ratio of 0.56, an interest coverage ratio of -8121.50x, free cash flow of $-22.84M (TTM), and net debt of $-4.52M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.89M
- P/E TTM
- -0.08x
- EPS TTM
- $-6.33
- P/B TTM
- 0.92x
- ROE TTM
- -3136.43%
- ROA TTM
- -287.21%
- Debt To Equity
- 1.27x
- Free Cash Flow TTM
- $-22.84M
Data as of 2025-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Vincerx Pharma, Inc. in?
Vincerx Pharma, Inc. (VINC) operates in the Pharmaceutical Preparations industry.
What exchange does VINC trade on?
Vincerx Pharma, Inc. (VINC) trades on the None.
When was Vincerx Pharma, Inc. (VINC)'s most recent SEC filing?
Vincerx Pharma, Inc. (VINC)'s most recent SEC filing is a Form 10-Q for the period ended 2025-03-31, filed with the SEC on 2025-05-15.
What is VINC's market cap?
Vincerx Pharma, Inc. (VINC) has a market capitalization of $1.89M as of 2025-03-31.
What is VINC's EPS (earnings per share)?
Vincerx Pharma, Inc. (VINC)'s trailing twelve month EPS is $-6.33 as of 2025-03-31.
What is VINC's ROE (return on equity)?
Vincerx Pharma, Inc. (VINC)'s trailing twelve month Return on Equity (ROE) is -3136.43% as of 2025-03-31.
What is VINC's ROA (return on assets)?
Vincerx Pharma, Inc. (VINC)'s trailing twelve month Return on Assets (ROA) is -287.21% as of 2025-03-31.
What is VINC's ROIC (return on invested capital)?
Vincerx Pharma, Inc. (VINC)'s trailing twelve month Return on Invested Capital (ROIC) is -844.17% as of 2024-09-30.
What is VINC's EV/EBITDA?
Vincerx Pharma, Inc. (VINC)'s trailing twelve month EV/EBITDA is 0.10x as of 2025-03-31.